Build Better Science Through Inclusive Cohort
A nonprofit partner connecting pharma, biotech with research‑ready, community‑trusted populations.
Why Inclusive Cohort Matters
Inclusive research leads to better science, stronger regulatory alignment, and improved real-world outcomes.
Drugs can perform differently across populations due to biological, genetic, and social factors, and trials that lack diversity risk missing important safety signals or variability in effectiveness. Inclusive enrollment supports evolving regulatory expectations, reduces downstream risk, and strengthens the credibility of clinical data. It also builds trust with patients and providers, improving adoption and long-term outcomes. Ultimately, inclusive cohort is not just ethical — it is a strategic advantage that helps ensure medicines are safer, more effective, and truly work for everyone.
Real‑World Proof Point
During COVID‑19, infrared laser thermometers showed reduced accuracy across different skin tones—highlighting how lack of diversity in validation can impact real‑world performance of:
​
✔ Drugs & biologics
✔ Medical devices
✔ Diagnostics
✔ Digital health & AI tools
Why it matters:
When diversity is missing, outcomes suffer—affecting effectiveness,
safety, adoption, and trust
DRN partners with pharma, biotech, and research organizations to support:
​
-
Equitable, trial-ready recruitment
-
Stronger data quality and generalizability
-
Ethical, patient-centered research practices
​
We don’t sell data. We build mission-aligned collaborations rooted in transparency, education, and health equity.
​
Inclusive research isn’t just the right thing to do—it’s the smart thing to do.
Our Cohort
We have community members who are interested and ready to participate in the right research study for them!
✔ Informed participants
✔ Opt‑in interest in clinical trials
✔ Reflects real‑world diversity
✔ Ongoing education & engagement
DRN does not sell data. All collaborations are mission‑aligned, ethical, and compliant.
Our Partner Value
🟦 Trial Readiness
🟩 Data Quality & Generalizability
🟪 Regulatory Alignment
🟨 Long‑Term Community Trust
DRN does not sell data. All collaborations are mission‑aligned, ethical, and compliant.
Cohort Interest Areas
-
Alzheimer’s disease & memory loss
-
Lupus & autoimmune diseases
-
Diabetes & high blood pressure
-
Depression & anxiety
-
Weight loss & obesity
-
Cancer screening & prevention
-
Long COVID / post-COVID conditions
-
Parkinson’s disease & brain health
-
Other therapeutic areas
While these represent the primary areas of interest, our cohort is not limited to these conditions. Diverse Research Now supports inclusive enrollment across all clinical studies, working with partners to reach underrepresented populations in a wide range of indications.